IBDoc® has now been on the market for over 2 years and it is transforming the way IBD patients manage their disease. IBDoc® is used by over a thousand patients in more than 15 countries and we now support 20 languages with Hebrew as the latest addition. BÜHLMANN as the only calprotectin company has been able
Social Links